Management of Graves' hyperthyroidism in pregnancy: Focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy

European Journal of Endocrinology

Volumn 160, Issue 1, 2009, Pages 1-8

  Laurberg, Peter ^a   Bournaud, Claire ^b   Karmisholt, Jesper ^a   Orgiazzi, Jacques ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LEVOTHYROXINE; LIOTHYRONINE; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THYROID ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE;

CORDOCENTESIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FETOMATERNAL TRANSFUSION; FETOTOXICITY; FETUS ECHOGRAPHY; FETUS RISK; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; REMISSION; REVIEW; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; THYROID FUNCTION; THYROID FUNCTION TEST; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TREATMENT CONTRAINDICATION; ADULT; CASE REPORT; DRUG CONTRAINDICATION; FEMALE; FETUS; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION;

ADULT; ANTITHYROID AGENTS; FEMALE; FETUS; GRAVES DISEASE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; THYROID FUNCTION TESTS; THYROIDECTOMY;

EID: 58249092354     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0663     Document Type: Review

References (52)

1. Davies TF, Ando T, Lin RY, Tomer Y & Latif R. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. Journal of Clinical Investigation 2005 115 1972-1983.
2. Laurberg P, Pedersen KM, Vestergaard H & Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. Journal of Internal Medicine 1991 229 415-420.
3. Laurberg P, Nygaard B, Glinoer D & Grussendorf M. Orgiazzi Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. European Journal of Endocrinology 1998 139 584-586.
4. Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, Kumahara Y & Miyai K. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. Journal of Clinical Endocrinology and Metabolism 1982 55 108-112.
5. Rotondi M, Cappelli C, Pirali B, Pirola I, Magri F, Fonte R, Castellano M, Agabiti Rosei E & Chiovato L. The effect of pregnancy on subsequent relapse from Graves' disease following a successful course of anti-thyroid drug therapy. Journal of Clinical Endocrinology and Metabolism 2008 93 3985-3988.
6. Atkinson S, McGregor AM, Kendall-Taylor P, Peterson MM & Smith BR. Effect of radioiodine on stimulatory activity of Graves' immunoglobulins. Clinical Endocrinology 1982 16 537-543.
7. Teng CS, Yeung RT, Khoo RK & Alagaratnam TT. A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine. Journal of Clinical Endocrinology and Metabolism 1980 50 1005-1010.
8. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G & Tørring O. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. European Journal of Endocrinology 2008 158 69-75.
9. Davis LE, Lucas MJ, Hankins GD, Roark ML & Cunningham FG. Thyrotoxicosis complicating pregnancy. American Journal of Obstetrics and Gynecology 1989 160 63-70.
10. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN & Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstetrics and Gynecology 1994 84 946-949.
11. Kriplani A, Buckshee K, Bhargava VL, Takkar D & Ammini AC. Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. European Journal of Obstetrics and Gynecology 1994 54 159-163.
12. Mestman JH. Hyperthyroidism in pregnancy. Best Practice and Research. Clinical Endocrinology and Metabolism 2004 18 267-288.
13. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O & Miyai K. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Journal of Clinical Endocrinology and Metabolism 1987 65 324-330.
14. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews 1997 18 404-433.
15. Momotani N, Noh J, Oyanagi H, Ishikawa N & Ito K. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. New England Journal of Medicine 1986 315 24-28.
16. Kung AW & Jones BM. A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy. Journal of Clinical Endocrinology and Metabolism 1998 83 514-518.
17. Ueta Y, Fukui H, Murakami H, Yamanouchi Y, Yamamoto R, Murao A, Santou Y, Taniguchi S, Mitani Y & Shigemasa C. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy. Thyroid 1999 9 179-182.
18. Amino N, Izumi Y, Hidaka Y, Takeoka K, Nakata Y, Tatsumi KI, Nagata A & Takano T. No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism 2003 88 5871-5874.
19. Mandel SJ, Brent GA & Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of Aplasia cutis. Thyroid 1994 4 129-133.
20. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT & Tenconi R. Methimazole embryopathy: delineation of the phenotype. American Journal of Medical Genetics 1999 83 43-46.
21. Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J & Clementi M. Adverse effects of prenatal methimazole exposure. Teratology 2001 64 262-266.
22. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA & Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. New England Journal of Medicine 2004 351 241-249.
23. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y & Mimura T. Maternal hyperthyroidism and congenital malformation in the offspring. Clinical Endocrinology 1984 20 695-700.
24. Mandel SJ & Cooper DS. The use of antithyroid drugs in pregnancy and lactation. Journal of Clinical Endocrinology and Metabolism 2001 86 2354-2359.
25. Dunn JT & Delange F. Damaged reproduction: the most important consequence of iodine deficiency. Journal of Clinical Endocrinology and Metabolism 2001 86 2360-2363.
26. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999 9 727-733.
27. Hernandez A, Martinez ME, Fiering S, Galton VA & St Germain D. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. Journal of Clinical Investigation 2006 116 476-484.
28. Nachum Z, Rakover Y, Weiner E & Shalev E. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. American Journal of Obstetrics and Gynecology 2003 189 159-165.
29. Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP & Kanhai HH. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. American Journal of Obstetrics and Gynecology 2005 192 171-177.
30. Thorpe-Beeston JG, Nicolaides KH & McGregor AM. Fetal thyroid function. Thyroid 1992 2 207-217.
31. LaFranchi S. Thyroid function in the preterm infant. Thyroid 1999 9 71-78.
32. Weeke J, Dybkjaer L, Granlie K, Eskjaer Jensen S, Kjaerulff E, Laurberg P & Magnusson B. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinologica 1982 101 531-537.
33. Burrow GN. Neonatal goiter after maternal propylthiouracil therapy. Journal of Clinical Endocrinology and Metabolism 1965 25 403-408.
34. Cheron RG, Kaplan MM, Larsen PR, Selenkow HA & Crigler JF Jr. Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. New England Journal of Medicine 1981 304 525-528.
35. Van Loon AJ, Derksen JT, Bos AF & Rouwé CW. In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil. Prenatal Diagnosis 1995 15 599-604.
36. Abuhamad AZ, Fisher DA, Warsof SL, Slotnick RN, Pyle PG, Wu SY & Evans AT. Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: case report and review of the literature. Ultrasound in Obstetrics and Gynecology 1995 6 368-371.
37. Bruner JP & Dellinger EH. Antenatal diagnosis and treatment of fetal hypothyroidism. A report of two cases. Fetal Diagnosis and Therapy 1997 12 200-204.
38. Ochoa-Maya MR, Frates MC, Lee-Parritz A & Seely EW. Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism. Thyroid 1999 9 1111-1114.
39. Gallagher MP, Schachner HC, Levine LS, Fisher DA, Berdon WE & Oberfield SE. Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves' disease during pregnancy: a problem revisited. Journal of Pediatrics 2001 139 896-900.
40. Cohen O, Pinhas-Hamiel O, Sivan E, Dolitski M, Lipitz S & Achiron R. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy. Prenatal Diagnosis 2003 23 740-742.
41. Lembet A, Eroglu D, Kinik ST, Gurakan B & Kuscu E. Non-invasive management of fetal goiter during maternal treatment of hyperthyroidism in Graves' disease. Fetal Diagnosis and Therapy 2005 20 254-257.
42. Luton D, Le Gac I, Vuillard E, Castanet M, Guibourdenche J, Noel M, Toubert ME, Léger J, Boissinot C, Schlageter MH, Garel C, Tébeka B, Oury JF, Czernichow P & Polak M. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. Journal of Clinical Endocrinology and Metabolism 2005 90 6093-6098.
43. Van Sande J, Costa MJ, Massart C, Swillens S, Costagliola S, Orgiazzi J & Dumont JE. Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells. Journal of Clinical Endocrinology and Metabolism 2003 88 366-374.
44. Momotani N, Noh JY, Ishikawa N & Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1997 82 3633-3636.
45. Nøhr SB & Laurberg P. Opposite variations in maternal and neonatal thyroid function induced by iodine supplementation during pregnancy. Journal of Clinical Endocrinology and Metabolism 2000 85 623-627.
46. Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M & Luton D. Congenital hyperthyroidism: the fetus as a patient. Hormone Research 2006 65 235-242.
47. Matsuura N, Harada S, Ohyama Y, Shibayama K, Fukushi M, IshikawaN, Yuri K, Nakanishi M, Yokota Y, Kazahari K & Oguchi H. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Pediatric Research 1997 42 214-218.
48. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ & Stagnaro-Green A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2007 92 S1-S47.
49. Srisupundit K, Sirichotiyakul S, Tongprasert F, Luewan S & Tongsong T. Fetal therapy in fetal thyrotoxicosis: a case report. Fetal Diagnosis and Therapy 2008 23 114-116.
50. McNab T & Ginsberg J. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease. Clinical and Investigative Medicine 2005 28 127-131.
51. Kempers MJ, van Tijn DA, van Trotsenburg AS, de Vijlder JJ, Wiedijk BM & Vulsma T. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. Journal of Clinical Endocrinology and Metabolism 2003 88 5851-5857.
52. Kempers MJ, van Trotsenburg AS, van Rijn RR, Smets AM, Smit BJ, de Vijlder JJ & Vulsma T. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease. Journal of Clinical Endocrinology and Metabolism 2007 92 2984-2991.